Divis Lab.

Divis Laboratories Ltd Quarterly Results

NSEBSE

₹6,105

(-0.05%)

Apr 30, 2025|10:59:55 AM

Invest wise with Expert advice

Financials

Profit & Loss Balance Sheet Cash Flow Ratios Results

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Dec-2024	Sept-2024	Jun-2024	Mar-2024	Dec-2023
Gross Sales	2,319	2,338	2,118	2,303	1,855
Excise Duty	0	0	0	0	0
Net Sales	2,319	2,338	2,118	2,303	1,855
Other Operating Income	0	0	0	0	0
Other Income	82	106	79	79	95
Total Income	2,401	2,444	2,197	2,382	1,950
Total Expenditure	1,576	1,622	1,496	1,572	1,366
PBIDT	825	822	701	810	584
Interest	0	1	0	2	0
PBDT	825	821	701	808	584
Depreciation	99	99	97	95	95
Minority Interest Before NP	0	0	0	0	0
Tax	174	218	179	160	122
Deferred Tax	-37	-6	-5	15	9
Reported Profit After Tax	589	510	430	538	358
Minority Interest After NP	0	0	0	0	0
Net Profit after Minority Interest	589	510	430	538	358
Extra-ordinary Items	0	0	0	0	0
Adjusted Profit After Extra-ordinary item	589	510	430	538	358
EPS (Unit Curr.)	22.2	19.2	16.2	20.25	13.5
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	0	0	0	0	0
Equity	53	53	53	53	53
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	35.57	35.15	33.09	35.17	31.48
PBDTM(%)	35.57	35.11	33.09	35.08	31.48
PATM(%)	25.39	21.81	20.3	23.36	19.29

Divis Lab.: Related NEWS

Divi’s Labs Signs Global Supply Deal, Plans ₹700 Crore Expansion

21 Apr 2025|01:04 PM

In a regulatory filing to the stock exchanges, Divi’s stated that the partnership is global in scope and is expected to significantly contribute to the company’s revenue over the coming years.